Yhim HY - Search Results

1

Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea.

Yi JH, Lee GW, Lee JH, Yoo KH, Jung CW, Kim DS, Lee JO, Eom HS, Byun JM, Koh Y, Yoon SS, Kim JS, Kong JH, Yhim HY, Yang DH, Yoon DH, Lim DH, Lee WS, Shin HJ. Yi JH, et al. Among authors: yhim hy. Blood Res. 2021 Dec 31;56(4):243-251. doi: 10.5045/br.2021.2021102. Blood Res. 2021. PMID: 34801988 Free PMC article.

2

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study.

Yhim HY, Kang HJ, Choi YH, Kim SJ, Kim WS, Chae YS, Kim JS, Choi CW, Oh SY, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Lee JJ, Sung HJ, Kim HJ, Lee DH, Suh C, Kwak JY. Yhim HY, et al. BMC Cancer. 2010 Jun 22;10:321. doi: 10.1186/1471-2407-10-321. BMC Cancer. 2010. PMID: 20569446 Free PMC article.

3

Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation.

Kim JW, Kim BS, Bang SM, Kim I, Kim DH, Kim WS, Yang DH, Lee JJ, Lee JH, Kim JS, Sohn SK, Yhim HY, Kwak JY, Yoon SS, Lee JS, Park S, Kim BK; Korean Society of Blood and Marrow Transplantation. Kim JW, et al. Among authors: yhim hy. Ann Hematol. 2011 Dec;90(12):1409-18. doi: 10.1007/s00277-011-1227-y. Epub 2011 Apr 6. Ann Hematol. 2011. PMID: 21468694

4

Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.

Yhim HY, Kim JS, Kang HJ, Kim SJ, Kim WS, Choi CW, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Huh J, Lee DH, Suh C, Kwak JY. Yhim HY, et al. Int J Cancer. 2012 Jul 1;131(1):235-43. doi: 10.1002/ijc.26352. Epub 2011 Aug 30. Int J Cancer. 2012. PMID: 21823120 Free article. Clinical Trial.

5

Seasonal variation in the occurrence of venous thromboembolism: a report from the Korean Venous Thromboembolism Working Party.

Jang MJ, Kim HJ, Bang SM, Lee JO, Yhim HY, Kim YK, Kim YK, Choi WI, Lee EY, Kim IH, Park S, Sohn HJ, Kim DK, Kim M, Oh D. Jang MJ, et al. Among authors: yhim hy. Thromb Res. 2012 Oct;130(4):e199-202. doi: 10.1016/j.thromres.2012.07.019. Epub 2012 Aug 15. Thromb Res. 2012. PMID: 22901545

6

Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.

Ahn JS, Yang DH, Jung SH, Chae YS, Sohn SK, Yhim HY, Kwak JY, Lee SR, Kim YK, Kim HJ, Lee JJ. Ahn JS, et al. Among authors: yhim hy. Ann Hematol. 2013 Jun;92(6):789-97. doi: 10.1007/s00277-013-1685-5. Epub 2013 Jan 29. Ann Hematol. 2013. PMID: 23358616

7

The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.

Yhim HY, Jang MJ, Kwak JY, Yim CY, Choi WI, Lee YC, Lee JO, Lee KW, Bang SM, Kim SH, Kim YK, Chang HJ, Oh D; Korean Venous Thromboembolism Working Party. Yhim HY, et al. Thromb Res. 2013 Apr;131(4):e133-40. doi: 10.1016/j.thromres.2013.01.025. Epub 2013 Feb 9. Thromb Res. 2013. PMID: 23399441

8

Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.

Ahn JS, Yang DH, Duk Choi Y, Jung SH, Yhim HY, Kwak JY, Sung Park H, Shin MG, Kim YK, Kim HJ, Lee JJ. Ahn JS, et al. Among authors: yhim hy. Am J Hematol. 2013 Sep;88(9):774-9. doi: 10.1002/ajh.23507. Epub 2013 Jul 23. Am J Hematol. 2013. PMID: 23760676 Free article.

9

High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.

Hyun SY, Cheong JW, Kim SJ, Min YH, Yang DH, Ahn JS, Lee WS, Ryoo HM, Do YR, Lee HS, Lee JH, Oh SY, Suh C, Yhim HY, Kim JS. Hyun SY, et al. Among authors: yhim hy. Biol Blood Marrow Transplant. 2014 Jan;20(1):73-9. doi: 10.1016/j.bbmt.2013.10.012. Epub 2013 Oct 17. Biol Blood Marrow Transplant. 2014. PMID: 24141009 Free article.

10

Busulfan-containing conditioning regimens are optimal preparative regimens for autologous stem cell transplant in patients with diffuse large B-cell lymphoma.

Shin HJ, Lee WS, Lee HS, Kim H, Lee GW, Song MK, Kim JS, Yhim HY, Chung JS. Shin HJ, et al. Among authors: yhim hy. Leuk Lymphoma. 2014 Nov;55(11):2490-6. doi: 10.3109/10428194.2014.882504. Epub 2014 Mar 7. Leuk Lymphoma. 2014. PMID: 24432893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page